Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOOKAD® Soluble VTP for Localized Prostate Cancer
NCT01875393Phase 3Completed
- Sponsor
- Steba Biotech
- Start
- May 2013
- Primary completion
- Dec 2014
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 3
01
Overview
A Phase 3 trial of talaporfin sodium in prostate cancer (PCa), sponsored by Steba Biotech. Started May 2013; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01875393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875393.